Anne McTiernan, MD, PhD

Represented: Researchers (Epidemiologists)

Conflicts of Interest:

As of May 31, 2015:

• Metagenics, Consultant
• Metaproteomics, Consultant
• Moving Forward Study, University of Illinois, Chicago (PI, Melinda Stolley), Consultant
• The Energy Balance and Breast Cancer Aspects Studies: EBBA-I and EBBA-II, Oslo University Hospital, Oslo, Norway (PI, Inger Thune), Consultant
• American Association for Cancer Research, Member
• American Association for Cancer Research, Cancer Prevention Committee, Member
• American College of Sports Medicine, Member and Grant Reviewer
• Breastcancer.org advisory committee, Member
• Cancer Prevention Research Institute of Texas Prevention Review Committee, Member
• Department of Health and Human Services (HHS) Physical Activity Guidelines Committee, Member
• Editorial Board Cancer Prevention Research, Member
• Editorial Board Journal of Women’s Health, Member
• Obesity Society, Member
• World Cancer Research Fund (WCRF) Continuous Update Project Panel, Member
• Breast Cancer Research Foundation, Grantee
• National Institutes of Health/National Cancer Institute, Grantee and Grant Reviewer
• National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI), Grantee
• Safeway Foundation, Grantee
• U.S. Department of Defense, Grant Reviewer
• Cancer Prevention Research Institute of Texas, Grant Reviewer
• State of Pennsylvania, Grant Reviewer
• Qatar, Grant Reviewer
• San Diego State, Grant Reviewer
• Catalan, Grant Reviewer
• beneSol, Stock
• Fred Hutchinson Cancer Research Center, Faculty
• University of Washington Schools of Public Health & Medicine, Faculty

McTiernan served as a member of the Advisory Panel on Clinical Trials from April 2014 - April 2016.